Charles River Laboratories to Present at Barclays Global Healthcare Conference
12 Mars 2024 - 1:00PM
Business Wire
Charles River Laboratories International, Inc. (NYSE: CRL)
announced today that it will present at the Barclays 26th Annual
Global Healthcare Conference on Wednesday, March 13th, at 10:15
a.m. ET. Management will present an overview of Charles River’s
strategic focus, business developments, and recent trends.
A live webcast of the presentation will be available through a
link that will be posted on the Investor Relations section of the
Charles River website at ir.criver.com. A webcast replay will be
accessible through the same website after the presentation and will
remain available for at least two weeks.
About Charles River
Charles River provides essential products and services to help
pharmaceutical and biotechnology companies, government agencies and
leading academic institutions around the globe accelerate their
research and drug development efforts. Our dedicated employees are
focused on providing clients with exactly what they need to improve
and expedite the discovery, early-stage development and safe
manufacture of new therapies for the patients who need them. To
learn more about our unique portfolio and breadth of services,
visit www.criver.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240312112305/en/
Investor Relations: Todd Spencer Corporate Vice President,
Investor Relations 781.222.6455 todd.spencer@crl.com
Charles River Laboratories (NYSE:CRL)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
Charles River Laboratories (NYSE:CRL)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024